Vertex Pharmaceuticals (VRTX) Stock Falls Amid Market Uptick: What Investors Need to Know
https://www.zacks.com/stock/news/2256422/vertex-pharmaceuticals-vrtx-stock-falls-amid-market-uptick-what-investors-need-to-know?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6v2-2256422
Apr 16, 2024 - Vertex Pharmaceuticals (VRTX) closed at $394.17 in the latest trading session, marking a -0.8% move from the prior day.
0
Vertex (VRTX) Begins Rolling NDA Filing for Acute Pain Drug
https://www.zacks.com/stock/news/2258650/vertex-vrtx-begins-rolling-nda-filing-for-acute-pain-drug?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2258650
Apr 19, 2024 - Vertex (VRTX) begins rolling NDA submission for its investigational non-opioid candidate, suzetrigine, for acute pain management. The submission is expected to be completed in second-quarter 2024.
0
2 Everlasting Big Pharma Stocks to Buy Today and Hold Forever
https://www.fool.com/investing/2024/04/20/2-everlasting-big-pharma-stocks-to-buy-today-and/?source=iedfolrf0000001
Apr 20, 2024 - These stocks probably won't be getting much cheaper.
0
Biotech Stock Roundup: BIIB, BMY's Q1 Earnings, INCY's Acquisition & Updates from VRTX
https://www.zacks.com/stock/news/2262685/biotech-stock-roundup-biib-bmy-s-q1-earnings-incy-s-acquisition-updates-from-vrtx?cid=CS-ZC-FT-analyst_blog|earnings_article-2262685
Apr 25, 2024 - Biogen (BIIB) and Bristol Myers (BMY) are in focus following Q1 earnings announcement.
0